9 Spam-Free Article(s) Found
Sort:
Relevance
Filter:
All
Article Searches
Bausch (BHC) Starts Study on Virazole for Coronavirus Infection http://www.zacks.com/stock/news/870392/bausch-bhc-starts-study-on-virazole-for-coronavirus-infection?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-870392 Apr 14, 2020 - Bausch (BHC) begins a clinical study on Virazole in combination with standard-of-care therapy to treat adults with respiratory distress due to COVID-19 in Canada.
Novartis To Initiate Hydroxychloroquine Study for Coronavirus http://www.zacks.com/stock/news/880449/novartis-to-initiate-hydroxychloroquine-study-for-coronavirus?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-880449 Apr 20, 2020 - Novartis (NVS) announces FDA's approval to evaluate hydroxychloroquine in hospitalized patients with COVID-19 in a late-stage study. The company is evaluating several of its drugs to treat COVID-19.
Analysts Estimate Incyte (INCY) to Report a Decline in Earnings: What to Look Out for http://www.zacks.com/stock/news/896061/analysts-estimate-incyte-incy-to-report-a-decline-in-earnings-what-to-look-out-for?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-896061 Apr 28, 2020 - Incyte (INCY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Vanda Begins Enrollment in Study for Severe Coronavirus Infection http://www.zacks.com/stock/news/874470/vanda-begins-enrollment-in-study-for-severe-coronavirus-infection?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-874470 Apr 16, 2020 - Vanda (VNDA) and The Feinstein Institutes for Medical Research initiate enrollment in the phase III ODYSSEY study on tradipitant to treat inflammatory lung injury associated with COVID-19 infection.
Gilead's (GILD) Coronavirus Drug Shows Promise, Shares Gain http://www.zacks.com/stock/news/876070/gileads-gild-coronavirus-drug-shows-promise-shares-gain?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-876070 Apr 17, 2020 - Treatment with Gilead's (GILD) experimental antiviral, remdesivir, shows rapid recoveries in fever and respiratory symptoms in COVID-19 patients in a Chicago hospital.
Roche's New Test to Detect Antibodies to Fight Coronavirus http://www.zacks.com/stock/news/876409/roches-new-test-to-detect-antibodies-to-fight-coronavirus?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-876409 Apr 17, 2020 - Roche (RHHBY) develops Elecsys, a new serology test, for the detection of antibodies against SARS-CoV-2, the virus causing COVID-19. The company plans to launch the same early next month.
Incyte Gets FDA Nod for Cholangiocarcinoma Drug Pemazyre http://www.zacks.com/stock/news/880319/incyte-gets-fda-nod-for-cholangiocarcinoma-drug-pemazyre?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-880319 Apr 20, 2020 - Incyte (INCY) gets FDA approval for Pemazyre for the treatment of previously-treated, unresectable, locally-advanced or metastatic cholangiocarcinoma.
Alexion to Evaluate Rare Disease Drug for COVID-19, Shares Up http://www.zacks.com/stock/news/882015/alexion-to-evaluate-rare-disease-drug-for-covid-19-shares-up?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-882015 Apr 21, 2020 - Alexion (ALXN) gains as it announces plans to initiate a study to evaluate Ultomiris for the COVID-19 infection.
Remdesivir Gets Emergency Approval: What's In Store for Gilead? http://www.zacks.com/stock/news/912891/remdesivir-gets-emergency-approval-whats-in-store-for-gilead?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-912891 May 04, 2020 - In a short span of time, Gilead's Remdesivir has been successful in treating some coronavirus patients. But will this give a boost to the pharmaceutical giant?

Pages: 1

Page 1